Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.75774 | 32 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.69422 | 31 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.77865 | 34 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.51848 | 24 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.63356 | 30 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.79682 | 32 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.74283 | 30 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.81535 | 36 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.70785 | 32 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.67782 | 30 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.89702 | 39 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.65651 | 30 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.76725 | 34 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.74819 | 33 |